2017 International Meeting on the Molecular Biology of Hepatitis B Viruses

2017年乙型肝炎病毒分子生物学国际会议

• 批准号: 9330983
• 负责人: Timothy M Block
• 金额: $ 0.63万
• 依托单位: HEPATITIS B FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-08-15 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9330983
• 关键词: Address; Animal Model; Anniversary; Antiviral Agents; Antiviral Therapy; Basic Science; Biochemistry; Biology; Biomedical Research; Cellular biology; Cessation of life; Chronic; Circular DNA; Cirrhosis; Communities; Development; Discipline; Disease; District of Columbia; Financial Support; Foundations; Fund Raising; Funding; Future; Gene Expression; Goals; Grant; Hepatitis B; Hepatitis Delta Virus; Home environment; Immunology; Individual; Infection; International; Joints; Knowledge; Light; Liver Failure; Liver diseases; Malignant Neoplasms; Mission; Modality; Molecular Biology; National Cancer Institute; National Institute of Allergy and Infectious Disease; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Oral; Pathogenesis; Population; Postdoctoral Fellow; Preventive vaccine; Primary carcinoma of the liver cells; Public Health; RNA Editing; Regulatory Element; Research; Research Personnel; Schedule; Scientist; Senior Scientist; Structure; Supervision; Therapeutic; Time; Travel; Underrepresented Minority; United States National Institutes of Health; Universities; Vaccines; Viral; Virus; Virus Diseases; Virus Shedding; cost; gene therapy; graduate student; interest; lecturer; meetings; minority investigator; pathogen; posters; protein expression; symposium; vector; virology; virus pathogenesis

2017 International HBV Meeting Project Summary/Abstract In this proposal, we request for funding to support the travel expenses for young scientists to attend and participate in the 2017 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for September 3-7, 2017 at the Omni Shoreham Conference Center and Hotel, Washington DC. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research on HBV continues, and the latest progress in the field is discussed and disseminated in a timely manner. The annual HBV meeting provides the forum for scientific exchanges and the dissemination of latest research information. The 2017 meeting will uphold and enhance the traditional format. It will consist of 8 oral scientific sessions and 2 poster sessions as well as less structured “networking” time. The scientific interactions will be facilitated by 3-4 keynote addresses. As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for supervising the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs is requested. It is expected that 300-400 attendees will register for the 2017 HBV meeting, which will mark the 33rd anniversary of the HBV meeting.

2017年国际HBV会议项目摘要/摘要 在这份提案中，我们要求提供资金，以支持年轻科学家参加会议的旅费， 参加定于2017年举行的2017年乙型肝炎B病毒分子生物学国际会议 2017年9月3日至7日在华盛顿特区的Omni Shoreham会议中心和酒店举行。本次会议是 唯一的论坛，聚集了国际社会的研究人员，专注于B肝炎病毒（HBV） 以及与之密切相关的丁型肝炎病毒（HDV）。世界上大约25%的人口 感染HBV。不幸的是，尽管预防性疫苗的可用性，许多新的感染发生 在世界范围内，这主要是因为由于成本和其他问题导致疫苗利用不足。而且对于 大约3.5亿人已经慢性感染HBV（其中大约1500万人是 与HDV共感染），疫苗没有治疗价值。因此，50万至100万人死亡 HBV/HDV的发病率。因此，必须继续对HBV进行基础研究， 及时讨论和传播该领域的最新进展。HBV年会 提供科学交流和最新研究信息的平台。2017年 会议将坚持和加强传统的形式。它将包括8个口头科学会议和2个海报 会议以及结构性较低的“网络”时间。科学互动将由3-4人促进 主旨发言。同过去一样，为尽量减少会议费用作出了巨大努力。 此外，自2005年以来，B型肝炎基金会一直坚定地承诺支持这次会议。 为组织会议提供永久住所并提供工作人员进行监督的条款 会议的召开和宣传，特别是向少数群体代表人数不足的大学进行宣传。在 为了允许初级和少数民族研究人员的参与，国家卫生研究院的支持，以帮助支付 会议费用已提出要求。预计将有300-400名与会者注册参加2017年HBV会议， 将纪念HBV会议33周年。